COMMUNIQUÉS West-GlobeNewswire

Aeglea BioTherapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights
06/08/2019
FDA Breakthrough Therapy Designation Received for Pegzilarginase in Treatment of Arginase 1 Deficiency Dosed First Patient in Global Pivotal Phase 3 PEACE Trial New Data from Arginase 1 Deficiency Phase 2 Extension [...]
MediWound to Report Second Quarter 2019 Financial Results and Host a Conference Call and Webcast on August 13
06/08/2019
YAVNE, Israel, Aug. 06, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]
Immutep Completes A$6M Entitlement Offer
06/08/2019
SYDNEY, Australia, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”) is pleased to announce the completion of its fully underwritten pro rata non-renounceable [...]
Seoul National University Hospital and Syapse Sign Multi-Year Renewal Agreement to Expand Access to Precision Medicine in South Korea
06/08/2019
Syapse and SNUH will work together to build Asia’s first learning health network of real-world data derived from the region’s leading precision oncology hospitals Co-hosted symposium of East Asian hospitals will share [...]
Avricore Health Welcomes Kiki Smith as Chief Financial Officer
06/08/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the " [...]
Arbutus to Participate at Wedbush PacGrow Healthcare Conference
06/08/2019
WARMINSTER, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Michael Sofia will [...]
Kiniksa Pharmaceuticals to Present at the 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
HAMILTON, Bermuda, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that Sanj K. Patel, Chief Executive Officer and Chairman of the Board of Kiniksa, will present at the [...]
XOMA Reports Second Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results
06/08/2019
Novartis’s iscalimab highlighted at key scientific conferences First patient dosed with gevokizumab in collaborator clinical study Sesen Bio announced intention to initiate Vicinium® BLA filing process in 2019 Royalty [...]
Wave Life Sciences Appoints Mark Baldry as Chief Commercial Officer
06/08/2019
Commercial build-out to support anticipated launch of suvodirsen and other future commercialized products CAMBRIDGE, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage [...]
T2Bacteria Panel is the First and Only In-Vitro Diagnostic Test to Receive Approval for a New Technology Add-on Payment by CMS
06/08/2019
Designation granted only to new technologies that demonstrate substantial clinical improvement LEXINGTON, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development [...]
Stemline Therapeutics Announces that CMS Grants New Technology Add-on Payment (NTAP) to ELZONRIS®
06/08/2019
NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, today [...]
Neuronetics Reports Second Quarter 2019 Financial and Operating Results
06/08/2019
MALVERN, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life [...]
Kamada Reports Financial Results for Second Quarter and First Six Months of 2019
06/08/2019
Total Revenues for Second Quarter of 2019 were $35.3 Million, a 4% Increase Year-Over-Year Total Revenues for First Six Months of 2019 were $62.1 Million, a 21% Increase Year-Over-Year Gross Profit for Second Quarter [...]
BioCryst Reports Second Quarter 2019 Financial Results
06/08/2019
—New drug application for once-daily oral BCX7353 for prophylaxis of hereditary angioedema attacks on-track for submission in Q4 2019— —Data from ongoing Phase 1 trial of oral Factor D inhibitor, BCX9930, expected in Q4 [...]
Indus Holdings, Inc. to Present at the Canaccord Genuity 39th Annual Growth Conference
06/08/2019
SALINAS, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Indus Holdings, Inc. ("Indus") (CSE:INDS), a leading, vertically-integrated cannabis company, today announced that Co-founder and Chief Executive Officer Robert Weakley [...]
Evelo Biosciences Reports Positive EDP1815 Interim Clinical Data in Psoriasis Patients at Low Dose in Ongoing Phase 1b Trial
06/08/2019
-EDP1815 was Well Tolerated with No Overall Difference Reported from Placebo- -Patients Dosed with EDP1815 Showed a Reduction in Mean Lesion Severity Score vs. Placebo- -Reductions Observed in Cellular Histological and [...]
Orchard Therapeutics to Webcast Presentation at the 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
BOSTON and LONDON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life- [...]
G1 Therapeutics to Participate in BTIG and Wedbush Healthcare Conferences in August
06/08/2019
RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that the company will participate in two investor conferences in [...]
Nabriva Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat [...]

Pages